À proposConditionsConfidentialitéContact
 
Actualisation
Against the Grain

Against the Grain

Samir Kakodkar
Date de sortie : 2022-02-27
© Copyright 2024 Samir Kakodkar
Against the Grain - QR Code
Libre0%
34 épisodes
Audio
Écouter sur Apple Podcasts
Libre0%
34 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2022-02-27
© Copyright 2024 Samir Kakodkar
L’épisode le plus récent
My Unbiased Breakdown of Zeposia (Ozanimod) for Ulcerative Colitis

My Unbiased Breakdown of Zeposia (Ozanimod) for Ulcerative Colitis

This is my review of Zeposia (Ozanimod), a new once a day oral medication for moderate to severe ...
Durée : 51:46
Lecture
This is my review of Zeposia (Ozanimod), a new once a day oral medication for moderate to severe ulcerative colitis. I go over the True North Study (https://www.nejm.org/doi/full/10.1056/NEJMoa2033617) in detail including efficacy and safety data. I have no conflicts of interest with any pharmaceutical companies. These are my opinions regarding Zeposia and other medications based on my personal/clinical experience and review of the literature.
Id. d’épisode : 1000552380473
GUID : https://samir3.podomatic.com/entry/2022-02-27T14_07_05-08_00
Date de publication : 27/2/2022 à 23:07:05

Description

Host: Samir Kakodkar, MD - specialist in Crohn's disease and ulcerative colitis Medical School: Northwestern Feinberg School of Medicine Internal Medicine Residency: Rush University Medical Center Fellowship in Gastroenterology and Hepatology: Advocate Lutheran General Hospital Advanced Fellowship in Inflammatory Bowel Disease (Crohn's and Colitis): Northwestern Memorial Hospital Practice Location 7900 N Milwaukee Ave Suite 19, Niles, IL 60714 For appointments: 847-318-9595 Contact: samir3@gmail.com YouTube channel: https://www.youtube.com/channel/UCSzuuqUFGgtcwpAbtL5b0xw If interested in scheduling a phone conversation with me, please visit https://calendly.com/samir3/against-the-grain Twitter: @KakodkarSamir 

Adresse du flux

https://samir3.podomatic.com/rss2.xml

Apple Podcasts : Avis des utilisateurs

Pas d'entrée